|
SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID
|
|
Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy
|
|
The emerging SARS-CoV-2 variants of concern
|
|
Preventing SARS-CoV-2 infection by blocking a tissue serine protease
|
|
Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results
|
|
Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review
|
|
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options
|
|
Methods to disinfect and decontaminate SARS-CoV-2: a systematic review of in vitro studies
|
|
The complex relationship between viruses and inflammatory bowel disease – review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic
|
|
Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges
|
|
Mechanisms and management of prothrombotic state in COVID-19 disease
|
|
Ocular manifestations of COVID-19
|
|
Management of a Parkinson’s disease patient with severe COVID-19 pneumonia
|
|
Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2
|
|
Convalescent Blood Products in COVID-19: A Narrative Review
|
|
Systematic review and meta-analysis of clinical outcomes of COVID-19 patients undergoing gastrointestinal endoscopy
|
|
COVID-19 and conjunctivitis: a meta-analysis
|
|
SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer
|
|
Missed opportunities to identify cryptococcosis in COVID-19 patients: a case report and literature review
|
|
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
|
|
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
|
|
Convalescent plasma appears efficacious and safe in COVID-19
|
|
Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
|
|
Optimizing diabetes mellitus care to improve COVID-19 outcomes in resource-limited settings in Africa
|
|
The impact of COVID-19 on tuberculosis: challenges and opportunities
|
|
Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report
|
|
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
|
|
Analysis of the effects of the first and second/third waves of the COVID-19 pandemic on an Interdisciplinary Endoscopy Unit in a German ‘hotspot’ area: a single-center experience
|
|
Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19
|
|
Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
|
|
Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19
|
|
COVID-19 vaccine acceptance among high-risk populations in Uganda
|
|
Bilio-pancreatic endoscopy during COVID-19 pandemic
|
|
Retinal vascular findings in patients with COVID-19
|
|
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City
|
|
Assessment of corneal endothelial cell morphology and anterior segment parameters in COVID-19
|
|
How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review
|
|
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase
|
|
Tocilizumab and liver injury in patients with COVID-19
|
|
Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster
|
|
Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis
|
|
A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection
|
|
Clinical characteristics of COVID-19 patients with complications: implications for management
|
|
Management of clozapine treatment during the COVID-19 pandemic
|
|
Why such excess of mortality for COVID-19 in Spain?
|
|
The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine
|
|
Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review
|
|
Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus
|
|
Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia
|
|
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
|
|
Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19
|
|
The importance of physical activity in management of type 2 diabetes and COVID-19
|
|
Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis
|
|
Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients
|
|
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study
|
|
COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review
|
|
COVID-19 vaccine hesitancy among staff and students in a Nigerian tertiary educational institution
|
|
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
|
|
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey
|
|
COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures
|
|
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak
|
|
Early fibroproliferative signs on high-resolution CT are associated with mortality in COVID-19 pneumonia patients with ARDS: a retrospective study
|
|
Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period
|
|
Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
|
|
Impact of preemptive hospitalization on health outcomes at the temporary COVID-19 hospital in Mexico City: a prospective observational study
|
|
Elevated glycohemoglobin is linked to critical illness in COVID-19: a retrospective analysis
|
|
The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services
|
|
High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
|
|
Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents
|
|
Vitamin D in the time of the coronavirus (COVID-19) pandemic – a clinical review from a public health and public mental health perspective
|
|
How did the first year of the COVID-19 pandemic affect urology practice in Arab countries? A cross-sectional study by the Arab Association of Urology research group
|
|
Keeping alive enterprises while embracing unprecedented COVID-19 restrictions
|
|
Benefits of COVID-19 viral screening of formerly incarcerated individuals during community reentry
|
|
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
|
|
Overt and non-overt disseminated intravascular coagulation and the potential role of heparin in the COVID-19 pandemic outbreak
|
|
Knowledge and awareness of COVID-19 epidemic preparedness and response among health care workers in Makkah city
|
|
Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
|
|
Neurological manifestations of long-COVID syndrome: a narrative review
|
|
Management of anti-VEGF intravitreal treatment at University Hospital Federico II of Naples during COVID-19 pandemic lockdown
|
|
Personal protective equipment use by healthcare workers in intensive care unit during the early phase of COVID-19 pandemic in Italy: a secondary analysis of the PPE-SAFE survey
|
|
Structural reorganization of the ophthalmological practice in a COVID-19 hub hospital: experience from European epicenter of the pandemic
|
|
Does the direct renin inhibitor have a role to play in attenuating severity of the outbreak coronavirus disease 2019 (COVID-19)?
|
|
Insights into the management of anorectal disease in the coronavirus 2019 disease era
|
|
Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
|
|
A glimpse into the future of systemic lupus erythematosus
|
|
Tying the past to the present: time tested knowledge with state-of-the-art technology in the fight against emerging and drug resistant microbes
|
|
Telemedicine in clinical gastroenterology practice: what do patients prefer?
|
|
The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management
|
|
The role of bronchoscopy in the diagnosis and management of pediatric pulmonary tuberculosis
|
|
Clostridioides difficile infection: curbing a difficult menace
|
|
A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases
|
|
The role of gut mycobiome in health and diseases
|
|
The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
|
|
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
|
|
Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response
|
|
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
|
|
Oropharyngeal swab for SARS-CoV-2 test causing atypical internal carotid artery dissection and stroke in a patient after mild COVID-19
|
|
Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
|
|
Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection
|
|
COVID-19 and cerebrovascular diseases: a comprehensive overview
|
|
Neurological manifestations and implications of COVID-19 pandemic
|
|
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study
|
|
The use of nebulized pharmacotherapies during the COVID-19 pandemic
|
|
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
|
|
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
|
|
Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
|
|
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
|
|
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
|
|
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease
|
|
Extensive cerebellar involvement and cognitive impairment in COVID-19-associated acute necrotizing encephalopathy
|
|
Three-month outcomes of recovered COVID-19 patients: prospective observational study
|
|
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
|
|
Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19
|
|
Therapeutic interventions for COVID-19: a living overview of reviews
|
|
Drug safety of frequently used drugs and substances for self-medication in COVID-19
|
|
IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
|
|
Potential specific therapies in COVID-19
|
|
Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
|
|
Early predictors for mechanical ventilation in COVID-19 patients
|
|
Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection
|
|
Systematic review of immunosuppressant guidelines in the COVID-19 pandemic
|
|
Transdermal approaches to vaccinations in the COVID-19 pandemic era
|
|
Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study
|
|
High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?
|
|
Does pre-existent physical inactivity have a role in the severity of COVID-19?
|
|
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis
|
|
Potential neurological symptoms of COVID-19
|
|
Effectiveness of corticosteroids on chest high-resolution computed tomography features of COVID-19 pneumonia
|
|
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
|
|
Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy
|
|
The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study
|
|
Pregnancy and breastfeeding during COVID-19 pandemic
|
|
ICU outcomes in Covid-19 patients with obesity
|
|
Definition and retrospective application of a clinical scoring system for COVID-19 triage at presentation
|
|
Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis
|
|
Persistent decline of hospitalizations for acute stroke and acute coronary syndrome during the second wave of the COVID-19 pandemic in Greece: collateral damage unaffected
|
|
Worrying situation regarding the use of dexamethasone for COVID-19
|
|
High-flow nasal cannula versus noninvasive ventilation in patients with COVID-19: a systematic review and meta-analysis
|
|
Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study
|
|
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China
|
|
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
|
|
Respiratory viral infections in the elderly
|
|
Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study
|
|
Utilizing telehealth to create a clinical model of care for patients with Batten disease and other rare diseases
|
|
Post-infectious neurological disorders
|
|
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
|
|
MOG antibody–associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report
|
|
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience
|
|
The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis
|
|
COVID-19 vaccine hesitancy: Pakistan struggles to vaccinate its way out of the pandemic
|
|
Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages
|
|
Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
|
|
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers
|
|
Low rate of COVID-19 vaccination in Africa: a cause for concern
|
|
COVID-19: should oral vaccination strategies be given more consideration?
|
|
Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India
|
|
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
|